Some of St. Jude Medical Devices Are About to Be Sold Off for $1.12 Billion
October 18, 2016 – by Reuters
Abbott Laboratories, which is in the process of buying St. Jude Medical for $25 billion, said the companies would sell some of their medical devices to Japan-based Terumo for about $1.12 billion.
Abbott said on Tuesday the deal is an important step toward completion of the St. Jude acquisition, which is scheduled to close by the year-end.
The deal is subject to the successful completion of Abbott’s acquisition of St. Jude and other approvals.
The divestiture was a nice win for the companies as it signaled that the deal remained on track to close before the year-end and the price seems “extremely lucrative,” Canaccord Genuity analysts wrote in a client note.
St. Jude’s STJ -0.28% shares rose 1.93%, their biggest intraday percentage jump since the deal with Abbott was announced in April, to $79.16. Abbott’s ABT -2.28% shares gained about1% to $40.96.
OrthoSpineNews
OrthoSpineNews.com is the preferred aggregator of all news in the orthopedic and spine industry. You can subscribe for our daily email, follow us on twitter or download our app for iPhone and Android.